Increased medial thalamic creatine- phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls

Journal of Child Neurology

Volumn 21, Issue 2, 2006, Pages 106-111

  Mirza, Yousha ^a   O'Neill, Joseph ^b   Smith, Ethan A ^a   Russell, Aileen ^a   Smith, Janet M ^a   Banerjee, S Preeya ^a   Bhandari, Rashmi ^a   Boyd, Courtney ^a   Rose, Michelle ^a   Ivey, Jennifer ^a   Renshaw, Perry F ^c   Rosenberg, David R ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; CREATINE PHOSPHATE;

ADOLESCENT; ARTICLE; BRAIN FUNCTION; BRAIN LEVEL; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MAJOR DEPRESSION; MALE; NEUROIMAGING; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHOOL CHILD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THALAMUS;

ADOLESCENT; BRAIN MAPPING; CHILD; CREATINE; DEPRESSIVE DISORDER, MAJOR; DOMINANCE, CEREBRAL; ENERGY METABOLISM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; OBSESSIVE-COMPULSIVE DISORDER; PHOSPHOCREATINE; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; THALAMUS;

EID: 33646828485     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738060210020201     Document Type: Article

References (51)

1. Rasmussen SA, Eisen JL: The epidemiology and differential diagnosis of obsessive compulsive disorder. J Clin Psychiatry 1992;53(Suppl):4-10.
2. Pauls DL, Alsobrook JP, Goodman W, et al: A family study of obsessive-compulsive disorder. Am J Psychiatry 1995;152:76-84.
3. Rauch SL, Savage CR: Investigating cortico-striatal pathophysiology in obsessive-compulsive disorders: Procedural learning and imaging probes, in Goodman WK, Rudorfer MV, Master JD (eds): Obsessive-Compulsive Disorder: Contemporary Issues in Treatment. Mahwah, NJ, Lawrence Erlbaum, 2000, 133-154.
4. Rosenberg DR, Keshavan MS: Toward a neurodevelopmental model of obsessive-compulsive disorder. Biol Psychiatry 1998;43:623-640.
5. Denckla MB: Neurological examination, in Rapoport JL (ed): Obsessive-Compulsive Disorder in Children and Adolescents. Washington, DC, American Psychiatric Press, 1989, 107-115.
6. Capstick N, Seldrup U: Obsessional states: A study in the relationship between abnormalities occurring at birth and subsequent development of obsessional symptoms. Acta Psychiatr Scand 1977;56:427-439.
7. Hillbom E: After effects of brain injuries. Acta Psychiatr Neurol Scand 1960;35:82-106.
8. McKeon J, McGuffin P, Robinson P: Obsessive compulsive symptomatology in children with Tourette's syndrome. J Am Acad Child Psychiatry 1987;26:69-73.
9. Schilder P: The organic background of obsessions and compulsions. Am J Psychiatry 1938;94:1397.
10. Jones EG: Cortical development and thalamic pathology. Schizophr Bull 1997;45(Suppl):145S.
11. Kim JJ, Lee MC, Kim J, et al: Grey matter abnormalities in obsessive-compulsive disorder: Statistical parametric mapping of segmented magnetic resonance images. Br J Psychiatry 2001; 179:330-334.
12. Gilbert AR, Moore GJ, Keshavan MS, et al: Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry 2000;57:449-456.
13. Smith EA, Russell A, Lorch E, et al: Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: A magnetic resonance spectroscopy study. Biol Psychiatry 2003;54:1399-1405.
14. Barker PB, Breiter SN, Soher BJ, et al: Quantitative proton spectroscopy of canine brain: In vivo and in vitro correlations. Magn Reson Med 1994;32:157-163.
15. Miller BL, Chang L, Booth R, et al: In vivo 1H MRS choline: Correlation with in vitro chemistry/histology. Life Sci 1996;58: 1929-1935.
16. Blusztajn JK, Wurtman RJ: Choline and cholinergic neurons. Science 1983;221:614-620.
17. Dawson RM, Hemington N, Irvine RF: The inhibition of diacylglycerol-stimulated intracellular phospholipases by phospholipids with a phosphocholine-containing polar group. A possible physiological role for sphingomyelin. Biochem J 1985;230:61-68.
18. Exton JH: Hormonal regulation of phosphatidylcholine breakdown. Adv Second Messenger Phosphoprotein Res 1990;24:152-157.
19. Exton JH: Phosphatidylcholine breakdown and signal transduction. Biochem Biophys Acta 1994;1212:26-42.
20. Loffelholz K: Receptor regulation of choline phospholipid hydrolysis. A novel source of diacylglycerol and phosphatidic acid. Biochem Pharmacol 1989;38:1543-1549.
21. Zeisel SH: Choline phospholipids: Signal transduction and carcinogenesis. FABEB J 1993;7:551-557.
22. Rosenberg DR, Amponsah A, Sullivan A, et al: Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging. J Child Neurol 2001;16:636-641.
23. Baxter LR Jr, Saxena S, Brady AL, et al: Brain mediation of obsessive-compulsive disorder symptoms: Evidence from functional brain imaging studies in the human and nonhuman primate. Semin Clin Neuropsychiatry 1996;1:32-47.
24. Rauch SL, Jenike MA, Alpert NM, et al: Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994;51:62-70.
25. Dager SR, Friedman SD, Parow A, et al: Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004;61:450-458.
26. Lyoo IK, Kong SW, Sung SM, et al: Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate. Psychiatry Res 2003;123:87-100.
27. Silveri MM, Parow AM, Villafuerte RA, et al: S-Adenosyl-L-methionine: Effects on brain bioenergetic status and transverse relaxation time in healthy subjects. Biol Psychiatry 2003;54:833-839.
28. Rosenberg DR, MacMaster FP, Keshavan MS, et al: Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 2000;39:1096-1103.
29. Mirza Y, Tang J, Russell A, et al: Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. J Am Acad Child Adolesc Psychiatry 2004;43:341-348.
30. Siesjo BK: Brain Energy Metabolism. Chichester, NY, John Wiley & Sons, 1978.
31. Caetano SC, Sassi R, Brambilla P, et al: MRI study of thalamic volumes in bipolar and unipolar patients and healthy individuals. Psychiatry Res 2001;108:161-168.
32. Kaufman J, Birmaher B, Brent D, et al: Schedule for Affective Disorders and Schizophrenia for School-Age children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997;36:980-988.
33. Scahill L, Riddle MA, McSwiggin-Hardin M, et al: Children's Yale-Brown Obsessive Compulsive Scale: Reliability and validity. J Am Acad Child Adolesc Psychiatry 1997;36:844-852.
34. Poznanski EO, Freeman LN, Mokros HB: Children's Depression Rating Scale Revised. Psychopharmacol Bull 1985;21:979-989.
35. Farchione TR, Moore GJ, Rosenberg DR: Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biol Psychiatry 2002;52:86-92.
36. Fitzgerald KD, Moore GJ, Paulson LA, et al: Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder. Biol Psychiatry 2000;47:174-182.
37. Gilbert AR, Rosenberg DR, Harenski K, et al: Thalamic volumes in patients with first-episode schizophrenia. Am J Psychiatry 2001;158:618-624.
38. Duyn JH, Moonen CT: Fast proton spectroscopic imaging of human brain using multiple spin-echoes. Magn Reson Med 1993;30:409-414.
39. Soher BJ, van Zijl PC, Duyn JH, et al: Quantitative proton MR spectroscopic maging of the human brain. Magn Reson Med 1996;35:356-363.
40. Birmaher B, Ryan ND, Williamson DE, et al: Childhood and adolescent depression: A review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry 1996;35:1575-1583.
41. Rasmussen SA, Tsuang MT: Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry 1986;143:317-322.
42. Tien AY, Pearlson GD, Machlin SR, et al: Oculomotor performance in obsessive-compulsive disorder. Am J Psychiatry 1992;149:641-646.
43. Rosenberg DR, Mirza Y, Russell A, et al: Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression vs. healthy controls. J Am Acad Child Adolesc Psychiatry 2004;43:1146-1153.
44. Ke Y, Cohen BM, Lowen S, et al: Biexponential transverse relaxation (T(2)) of the proton MRS creatine resonance in human brain. Magn Reson Med 2002;47:232-238.
45. Baslow MH: Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review. Neurochem Int 2002;40:295-300.
46. Moreno A, Ross BD, Bluml S: Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion. J Neurochem 2001;77:347-350.
47. Ebert D, Speck O, Konig A, et al: 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: Evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Res 1997;74:173-176.
48. Bartha R, Stein MB, Williamson PC, et al: A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry 1998;155:1584-1591.
49. Russell A, Cortese B, Lorch E, et al: Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 2003;13(Suppl 1):S31-S38.
50. Ross BD, Bluml S: Magnetic resonance spectroscopy of the human brain. Anat Rec B New Anat 2001;265:54-84.
51. Garber HJ, Ananth JV, Chiu LC, et al: Nuclear magnetic resonance study of obsessive-compulsive disorder. Am J Psychiatry 1989;146:1001-1005.